Ugur Sener, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Merck Inc & Co
    Topic:
    Von Hippel Lindau disease
    Date added:
    12/11/2024
    Date updated:
    12/11/2024
    Relationship end date:
    12/03/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Alexion
    Topic:
    Neurofibromatosis Type 1
    Date added:
    12/11/2024
    Date updated:
    12/11/2024
    Relationship end date:
    12/12/2024
Return to 2025 Inova Fairfax Neuroscience Grand Rounds: Updates on Glioma Treatments - Molecularly Targeted Therapies and Other Novel Approaches